(Q43130496)

English

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

scientific article published in March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 November 2017

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

14 November 2017

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

mipomersen parent acid

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

14 November 2017

William C Cromwell

object named as

William C Cromwell

6

0 references

object named as

Robin H Lachmann

7

0 references

author name string

Frederick J Raal

1

1 reference

Europe PubMed Central

14 November 2017

Raul D Santos

2

1 reference

Europe PubMed Central

14 November 2017

A David Marais

4

1 reference

Europe PubMed Central

14 November 2017

Min-Ji Charng

5

1 reference

Europe PubMed Central

14 November 2017

Daniel Gaudet

8

1 reference

Europe PubMed Central

14 November 2017

Ju L Tan

9

1 reference

Europe PubMed Central

14 November 2017

Scott Chasan-Taber

10

1 reference

Europe PubMed Central

14 November 2017

Diane L Tribble

11

1 reference

Europe PubMed Central

14 November 2017

Joann D Flaim

12

1 reference

Europe PubMed Central

14 November 2017

Stanley T Crooke

13

1 reference

Europe PubMed Central

14 November 2017

language of work or name

0 references

publication date

1 March 2010

1 reference

Europe PubMed Central

14 November 2017

1 reference

Europe PubMed Central

14 November 2017

375

1 reference

Europe PubMed Central

14 November 2017

998-1006

1 reference

Europe PubMed Central

14 November 2017

9719

1 reference

Europe PubMed Central

14 November 2017

Monogenic hypercholesterolemia: new insights in pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of LDL apheresis in patients with severe hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Recommendations for the use of LDL apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical management of dyslipidemia: clinical and experimental evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation in patients with homozygotic familial hypercholesterolemia previously treated by end-to-side portocaval shunt and ileal bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell and molecular biology of the assembly and secretion of apolipoprotein B-containing lipoproteins by the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Other therapies for reducing low-density lipoprotein cholesterol: medications in development

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-species comparison of in vivo PK/PD relationships for second-generation antisense oligonucleotides targeting apolipoprotein B-100.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome and prognostic markers in severe drug-induced liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Current perspectives on statins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960284-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)60284-X

1 reference

Europe PubMed Central

14 November 2017

1 reference

Europe PubMed Central

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43130496&oldid=2041803722"